Sign in

CIK 0001635088

  • Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
Operating
EIN
981173944
Phone
+44 12955950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
  1. 4 Grant or award Pres&Chief Investment Officer acquired 18,836,547 shares (grant or award)
  2. 4 Grant or award President & COO acquired 204,000 shares (grant or award)
  3. 4 Shares withheld for taxes CFO gave up 2,341 shares (to pay taxes)
  4. 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
  5. 4 Shares withheld for taxes President & COO gave up 10,945 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Accounting Officer gave up 958 shares (to pay taxes)
  7. 4 Shares withheld for taxes Director gave up 215 shares (to pay taxes)
  8. 4 Grant or award Director acquired 1,555 shares (grant or award)
  9. 4 Grant or award Director acquired 1,702 shares (grant or award)
  10. 4 Shares withheld for taxes CFO gave up 2,340 shares (to pay taxes)
  11. 4 Shares withheld for taxes CFO gave up 2,129 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Accounting Officer gave up 3,087 shares (to pay taxes)
  13. 4 Shares withheld for taxes President & COO gave up 10,945 shares (to pay taxes)
  14. 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
  15. 4 Shares withheld for taxes CFO gave up 2,341 shares (to pay taxes)
  16. 4 Shares withheld for taxes President & COO gave up 16,003 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Accounting Officer gave up 1,363 shares (to pay taxes)
  18. 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
  19. 4 Shares withheld for taxes CFO gave up 2,340 shares (to pay taxes)
  20. 4 Shares withheld for taxes Director gave up 83 shares (to pay taxes)

Page 12 of 26 · 511 filings